FrameDialFacts · Frames · Receipts
Quick ReadDeep ReadFramesField GuideReframeQuizSign in
Today’s Stories›Business & Markets

Sun Pharma agrees to acquire Organon in an all-cash deal valued at $11.75 billion

Monday, April 27, 2026Business & MarketsWell-covered3 frames

The Facts

  • Sun Pharma has agreed to acquire Organon & Co. in an all-cash transaction with an enterprise value of about $11.75 billion, including debt.
  • Under the agreement, Sun Pharma will pay $14 per share and acquire all outstanding shares of Organon.
  • Organon was spun off from Merck in 2021 and focuses on areas including women's health and biosimilars.
  • The acquisition is part of Sun Pharma's effort to expand its global business and strengthen its portfolio in specialty or innovative medicines.
  • Multiple reports describe the transaction as the largest acquisition by an Indian pharmaceutical company or the largest overseas acquisition by an Indian pharmaceutical company.
  • The transaction has been approved by both companies' boards but still requires customary regulatory approvals and approval from Organon shareholders.
  • The companies have said they expect the deal to close in early 2027, subject to those approvals and other closing conditions.
Frames
Facts
Just the facts
Cable News Mode
Left
Facts
Right
Just the facts
Analytical frames for this storyTap to explore

Context

What does Sun Pharma get through this acquisition?

Sun Pharma would gain full ownership of Organon, a New Jersey-based healthcare company formed from Merck's 2021 spinoff that operates in women's health, biosimilars and established medicines Business Standard,CNBC,Hindu.

Why is Sun Pharma pursuing the deal now?

Reuters and other reports say Sun Pharma has been trying to build its higher-margin specialty and innovative medicines business and broaden its global reach, including in areas such as women's health and biosimilars Aol,Yahoo News,mint.

What still has to happen before the acquisition is completed?

The deal is not closed yet: it still needs regulatory clearance, approval from Organon shareholders and satisfaction of other customary closing conditions, with the companies targeting early 2027 for completion India Today,WSJ.

View all 117 sources

Wire services (4)

APThe TelegraphSun Pharma to acquire US-based Organon & Co at $11.75 billio...
ReutersAolSun Pharma to buy US drugmaker Organon for $11.75 billion in...
ReutersYahoo NewsIndia's Sun Pharma to buy US-listed Organon in $11.75 billio...
ReutersReutersIndia's Sun Pharma to buy Organon in $11.75 billion all-cash...

Independent coverage (50)

mintSun Pharma's Organon buy took shape over three months of int...
The Times of IndiaGujarat'Sun Pharma to acquire Organon in $11.8bn all-cash de...
Economic TimesSun Pharma to acquire Organon for $11.75 billion in India's ...
NASDAQ Stock MarketStock Market Today, April 27: Organon Shares Surge After Sun...
The Motley FoolStock Market Today, April 27: Organon Shares Surge After Sun...
Economic TimesOrganon gives Sun Pharma scale and reach, but challenge lies...
Economic TimesSun's strong gravity helps India Inc's pull - The Economic T...
@businesslineSun Pharma-Organon deal: Outlook is mixed
Business StandardLack of growth visibility at Organon could cap Sun Pharma's ...
ThePrintIndia's Sun Pharma takes biosimilar leap with $11.75 billion...
Forbes IndiaSun Pharma's $11.75 billion buy: Is the Organon deal valuati...
Rediff.com India Ltd.What Dilip Shanghvi said on Sun Pharma's Organon Buy
Telangana TodaySun Pharma chairman calls Organon deal both happy and anxiou...
Trade BrainsPharma stock jumps 9% after signing $11.75 Bil deal to acqui...
wallstreet:onlineSun Pharma unterzeichnet endgültige Vereinbarung zur Übernah...
MoneyControlHere's what Sun Pharma will be getting out of $11.75-bn Orga...
Yahoo! FinanceIndia's Sun Pharma Plots $12 Billion Organon Buyout For Glob...
Telangana TodaySun Pharma to acquire Organon in USD 11.75 billion deal
FortuneIndiaSun Pharma's $11.75-bn Organon deal to be part cash, largely...
MoneyControlSun Pharma targets rapid deleveraging of balance sheet to di...
cnbctv18.comSun Pharma to use Organon's global reach, keep focus on R&D:...
FirstpostWhat are biosimilars and why Sun Pharma-Organon deal matters
News18Sun Pharma To Acquire Organon For $11.75 Billion: A Look At ...
Asianet News Network Pvt LtdSun Pharma to buy Organon for $11.75B; shares jump over 7 pe...
BlockonomiSun Pharma's $11.75B Acquisition Sends Organon (OGN) Stock S...
Republic WorldMarkets Convinced On US-Iran War Outcome: Stock Market Exper...
wallstreet:onlineMega-Übernahme entfacht Kursfeuerwerk am Pharma-Markt
RTE.ieSun Pharma to buy US drugmaker Organon for $11.75 billion
LatestLYBusiness News | Sun Pharma to Acquire Organon for $11.75 Bil...
Asian News International (ANI)Sun Pharma to acquire Organon for $11.75 Billion in all-cash...
Economic TimesSun Pharma: How a small Kolkata trader became a global buyou...
Yahoo! FinanceSun Pharma Buys New Jersey-Based Organon in $12 Billion Deal
cnbctv18.com'Debt Averse, Not Risk Averse': Dilip Shanghvi on Sun Pharma...
Zee BusinessMega Pharma Deal: Inside Rs 1.11 Lakh-Cr Sun Pharma-Organon ...
India Infoline LtdWhy Sun Pharma is up today? - Reasons explained | India Info...
GoodreturnsSun Pharma's Biggest Global Bet, Buys Organon in $11.75 Bill...
Business StandardSun Pharmaceuticals enters definitive agreement to acquire O...
finanzen.atMilliarden-Übernahme im Pharmasektor: Sun Pharmaceutical gre...
mintSun Pharma acquires Organon: growth engine or debt trap? | S...
mintSun Pharma Buys US-Based Organon For $11.75 Billion | India'...
finanzen.chSun Pharmaceutical To Buy Organon For $11.75 Bln
RTTNewsSun Pharmaceutical To Buy Organon For $11.75 Bln
Free Press JournalSun Pharma Stock Climbs Over 9% After $11 Bn Organon Deal An...
https://www.outlookbusiness.com/Sun Pharma Shares Jump Over 7 Pc; Market Valuation Surges By...
Business StandardSun Pharma to buy Organon for $11.75 bn, enter top 25 global...
cnbctv18.comSun Pharma Dividend Update: What 6.6 lakh retail holders nee...
Markets InsiderSun Pharma to acquire Organon for $14 per share in all-cash ...
MorningstarIndia's Sun Pharma to Buy U.S. Healthcare Company Organon in...
NewsXSun Pharma's Organon Acquisition: Sun Pharma To Acquire US-B...
Barchart.comShareholder Alert: Ademi LLP investigates whether Organon & ...
About these frames
The Analyst: Costs, jobs, inflation, growth, incentives, markets, tradeoffs. Follow the money.
The First Responder: Who gets hurt or helped. Quality of life, vulnerable groups, public health, human cost and benefit.
The Bridge Builder: Heritage, community, national identity, social cohesion, cultural preservation, trust, polarization. What does this mean for who people are and how they hold together?

Continue Reading

More in Business & Markets

SIPRI says global military spending rose to about $2.89 trillion in 2025

Global military spending reached about $2.89 trillion in 2025, up 2.9% from 2024 and marking an 11th straight annual...

Business & MarketsEconomic Stakes vs. Order & Institutions
Also through Human Impact

UK deploys APKWS anti-drone weapons on RAF Typhoon jets in the Middle East

The UK has deployed the Advanced Precision Kill Weapon System, or APKWS, on RAF Typhoon jets operating in the Middle...

International AffairsHuman Impact vs. Economic Stakes
From today's briefing

Trump says Iran’s oil pipelines could fail within days if exports remain blocked

President Donald Trump said in a Fox News interview that Iran has about three days before parts of its oil pipeline...

U.S. PoliticsBoundaries & Dignity vs. Economic Stakes

See this differently than someone you know would? Two ways to keep it going.

Reframe any article →

The dial works on any URL — paste an article you read elsewhere this week.

← Previous
Penny Wong to visit Japan, China and South Korea for energy security talks
Australia's foreign minister, Penny Wong, said she will travel this week to Japan, China and South Korea for talks...
International AffairsEconomic Stakes vs. Belonging & Identity
Next →
U.S. envoy urges Taiwan legislature to advance supplemental defense budget
The top U.S. diplomat in Taiwan, Raymond Greene of the American Institute in Taiwan, urged Taiwan’s opposition-led...
U.S. PoliticsOrder & Institutions vs. Belonging & Identity
Back to all stories
FrameDial

Facts first. Framing you control.

Consensus facts with cited sources and contrasting analytical frames for every top story.

Navigate

Today’s StoriesArchiveAnalytical FramesField GuideDiscover Your Frame

Company

Skylark CreationsSign InTerms of ServicePrivacy Policy

© 2026FrameDial · frame-dial.news

Made by Skylark Creations